Filter articles using the following links

BioEurope Spring, Vienna, Austria

GenSight Biologics Announces its 2019 Financial Calendar

GenSight Biologics Reports its Cash Position as of December 31, 2018

GenSight Biologics reports sustained quality of life improvements at Week 72 of Phase III REVERSE clinical trial of GS010 for the treatment of Leber Hereditary Optic Neuropathy (LHON)

45th NANOS Annual Meeting, Las Vegas, Nevada, US

Oddo BHF Forum, Lyon, France

37th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA

World Orphan Drug Congress Europe, Barcelona, Spain

GenSight Biologics enrolls first subject in first-in-man PIONEER Phase I/II clinical trial of GS030 combining gene therapy and Optogenetics for the treatment of Retinitis Pigmentosa

GenSight Biologics Reports its Cash Position as of September 30, 2018